Drug intelligence / Profile preview

2-(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]thiopyran-3-carboxylic acid

Development stage
Preclinical
Lead developer
Novo Nordisk
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the thienothiopyran class and is structurally classified as an alpha amino acid derivative. It was developed as a nonphosphorus and nonpeptide inhibitor of protein tyrosine phosphatase 1B (PTP1B), an enzyme implicated in negative regulation of insulin signaling. By selectively inhibiting PTP1B through structure-based design—specifically targeting Asp48 for selectivity—the compound demonstrates potential utility in modulating insulin sensitivity and has been explored as a lead for antidiabetic drug development. The molecular formula is C10H9NO5S2 with an average mass of approximately 287.31 g/mol. It remains experimental with no approved indications or advanced clinical trials reported to date[1][3][8].

Other names
2-(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]thiopyran-3-carboxylic acid2-(carboxyformamido)-4H,5H,7H-thieno[2,3-c]thiopyran-3-carboxylic acid2-(carboxycarbonyl)amino]-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylic acid5H-Thieno[2,3-c]thiopyran-3-carboxylic acid, 2-[carboxycarbonyl)amino]-4,7-dihydro-
02

Targets

PTPN1 (Protein tyrosine phosphatase 1B)

Beyond the preview

Go deeper on 2-(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]thiopyran-3-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(oxalyl-amino)-4,7-dihydro-5h-thieno[2,3-c]thiopyran-3-carboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call